JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2626
CALL
Cushman & Wakefield Ltd
CWK
$2.85B
| $7.59M | ﹤0.01% |
+729,900
| New | +$7.55M |
2024 Q2
0 quarters
|
|
|
RVNC
2627
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7.57M | ﹤0.01% |
2,944,861
-208,262
| -7% | -$711K |
2014 Q1
41 quarters
|
|
2628
Veracyte
VCYT
$3.66B
| $7.57M | ﹤0.01% |
349,130
+268,466
| +333% | +$5.64M |
2017 Q3
27 quarters
|
|
2629
Pediatrix Medical
MD
$2.09B
| $7.56M | ﹤0.01% |
1,001,821
-68,238
| -6% | -$564K |
2013 Q2
44 quarters
|
|
2630
PUT
Expedia Group
EXPE
$32B
| $7.56M | ﹤0.01% |
60,000
-28,400
| -32% | -$3.5M |
2022 Q3
7 quarters
|
|
2631
CALL
Zimmer Biomet
ZBH
$16.8B
| $7.55M | ﹤0.01% |
69,600
-40,000
| -36% | -$4.72M |
2023 Q3
3 quarters
|
|
2632
Health Catalyst
HCAT
$132M
| $7.55M | ﹤0.01% |
1,182,103
+212,939
| +22% | +$1.37M |
2019 Q3
19 quarters
|
|
2633
Overlay Shares Large Cap Equity ETF
OVL
$461M
| $7.54M | ﹤0.01% |
170,930
+88,670
| +108% | +$3.72M |
2022 Q4
6 quarters
|
|
2634
CALL
Align Technology
ALGN
$10.3B
| $7.53M | ﹤0.01% |
31,200
+200
| +0.6% | +$55.7K |
2024 Q1
1 quarter
|
|
2635
CALL
Elevance Health
ELV
$83.8B
| $7.53M | ﹤0.01% |
13,900
-14,900
| -52% | -$7.88M |
2021 Q3
11 quarters
|
|
2636
Alector
ALEC
$205M
| $7.52M | ﹤0.01% |
1,656,525
-59,239
| -3% | -$305K |
2019 Q1
21 quarters
|
|
2637
PagerDuty
PD
$1.21B
| $7.51M | ﹤0.01% |
327,584
-213,110
| -39% | -$4.44M |
2019 Q2
20 quarters
|
|
|
ALEX
2638
DELISTED
Alexander & Baldwin
ALEX
| $7.51M | ﹤0.01% |
442,767
+71,419
| +19% | +$1.17M |
2013 Q2
44 quarters
|
|
2639
Gray Television
GTN
$472M
| $7.51M | ﹤0.01% |
1,443,888
-75,139
| -5% | -$440K |
2015 Q2
36 quarters
|
|
2640
CALL
Allstate
ALL
$56.8B
| $7.5M | ﹤0.01% |
+47,000
| New | +$7.84M |
2024 Q2
0 quarters
|
|
2641
CALL
Toll Brothers
TOL
$12.6B
| $7.5M | ﹤0.01% |
+65,100
| New | +$7.88M |
2024 Q2
0 quarters
|
|
|
2642
PUT
Toll Brothers
TOL
$12.6B
| $7.5M | ﹤0.01% |
+65,100
| New | +$7.88M |
2024 Q2
0 quarters
|
|
2643
Tidewater
TDW
$4.09B
| $7.49M | ﹤0.01% |
78,717
-152,891
| -66% | -$15.1M |
2013 Q2
44 quarters
|
|
2644
ImmunityBio
IBRX
$10.8B
| $7.48M | ﹤0.01% |
1,183,416
-252,330
| -18% | -$1.66M |
2015 Q3
35 quarters
|
|
2645
PUT
Pfizer
PFE
$157B
| $7.46M | ﹤0.01% |
266,600
-308,300
| -54% | -$8.49M |
2013 Q2
44 quarters
|
|
2646
Cannae Holdings
CNNE
$674M
| $7.44M | ﹤0.01% |
409,997
+64,748
| +19% | +$1.26M |
2017 Q4
26 quarters
|
|
2647
PUT
Ferrari
RACE
$68.1B
| $7.43M | ﹤0.01% |
18,200
-26,800
| -60% | -$11.1M |
2023 Q3
3 quarters
|
|
2648
PUT
The Mosaic Company
MOS
$6.78B
| $7.42M | ﹤0.01% |
256,600
| – | – |
2023 Q4
2 quarters
|
|
2649
AtriCure
ATRC
$2.79B
| $7.4M | ﹤0.01% |
325,147
-145,865
| -31% | -$3.37M |
2017 Q3
27 quarters
|
|
2650
PUT
Blackrock
BLK
$166B
| $7.4M | ﹤0.01% |
9,400
-2,200
| -19% | -$1.72M |
2023 Q3
3 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.